Aurobindo Pharma reports 6% rise in Q3 consolidated net profit

10 Feb 2017 Evaluate

Aurobindo Pharma has reported results for third quarter ended December 31, 2016. 

The company has reported 4.98% fall in its net profit at Rs 441.02 crore for the quarter under review as compared to Rs 464.14 crore for the same quarter in the previous year. However, total income of the company increased by 4.99% at Rs 2523.40 crore for the quarter under review as compared Rs 2403.48 crore for the corresponding quarter previous year.  

On the consolidated basis, the company has reported 6.30% rise in its net profit after tax, minority interest and share of profit of associates at Rs 578.59 crore for the quarter ended December 31, 2016, as compared to Rs 544.31 crore for the same quarter in the previous year. Total income of the company increased by 11.41% at Rs 3914.10 crore for the quarter under review as compared Rs 3513.14 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1102.05 18.45 (1.70%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.